Chescapmanager LLC - Q1 2023 holdings

$636 Thousand is the total value of Chescapmanager LLC's 43 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 50.0% .

 Value Shares↓ Weighting
ATVI SellACTIVISION BLIZZARD INCcall$55,325
+8.5%
646,400
-2.9%
8.70%
-27.2%
WSC SellWILLSCOT MOBIL MINI HLDNG CO$42,954
-0.0%
916,259
-3.7%
6.76%
-32.9%
USFD SellUS FOODS HLDG CORP$27,384
+7.1%
741,323
-1.3%
4.31%
-28.1%
EXPE SellEXPEDIA GROUP INC$15,428
-6.8%
159,000
-15.9%
2.43%
-37.5%
TBPH SellTHERAVANCE BIOPHARMA INC$6,757
-29.2%
622,738
-26.8%
1.06%
-52.5%
SLB SellSCHLUMBERGER LTDcall$6,138
-71.3%
125,000
-68.8%
0.96%
-80.7%
ExitCAZOO GROUP LTD*w exp 08/26/202$0-312,500
-100.0%
-0.00%
ExitNAVITAS SEMICONDUCTOR CORP$0-55,666
-100.0%
-0.05%
NOMD ExitNOMAD FOODS LTD$0-35,293
-100.0%
-0.14%
CZR ExitCAESARS ENTERTAINMENT INC NE$0-20,031
-100.0%
-0.20%
SLB ExitSCHLUMBERGER LTD$0-130,000
-100.0%
-1.63%
FUN ExitCEDAR FAIR L Pdepositry unit$0-178,496
-100.0%
-1.73%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMAZON COM INC28Q3 20237.2%
CARA THERAPEUTICS INC28Q3 20234.3%
THERAVANCE BIOPHARMA INC28Q3 20235.7%
ALPHABET INC26Q3 20235.9%
Nomad HLDGS Ltd25Q4 20224.6%
CRONOS GROUP INC23Q3 202322.6%
DISH NETWORK CORPORATION22Q2 20223.2%
BRISTOL-MYERS SQUIBB CO21Q3 20224.5%
PENN NATL GAMING INC19Q2 20224.3%
MARTIN MARIETTA MATLS INC17Q3 20215.0%

View Chescapmanager LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR/A2022-02-11
13F-HR2022-02-11

View Chescapmanager LLC's complete filings history.

Compare quarters

Export Chescapmanager LLC's holdings